
    
      The study used data from Taiwan Health Insurance Research Database; the investigators
      conducted a population-based cohort study in Taiwan. Case consisted of all patients who had a
      first diagnosis of chronic kidney disease for the period between 1997 and 2008. The
      investigators utilized the use of Proton pump inhibitor from chronic kidney disease patients.
    
  